Clinical PET/MRI

Cardiovascular imaging

Acknowledgments We would like to thank Sabine Frank, Susan Notohamiprodjo and Alberto Villagran for their assistance preparing this chapter. Introduction In recent years, numerous imaging modalities have been developed to diagnose cardiac disease noninvasively and to measure structural, functional, and…

Neurologic imaging

Acknowledgments VG has received funding from the Swiss National Science Foundation (project n. 185028, 188355 and 169876), the Velux Foundation, the Schmidheiny Foundation and research/teaching support through her institution from Siemens Healthineers, GE Healthcare, Roche, Merck, Cerveau Technologies and Life…

Head and neck imaging

Introduction The region of the head and neck involves complex anatomic structures, including the skull base, temporal bone, orbit, oral cavity, paranasal sinuses, and aerodigestive tract. Various kinds of pathology, including trauma, infection, congenital disease, and benign and malignant tumors…

Radiopharmaceuticals and contrast agents

Introduction to PET radiopharmaceuticals and radionuclides PET radiopharmaceuticals are radioactive tracers used for diagnostic purposes in PET imaging. They consist of two main components, a positron-emitting radionuclide and a tracer/carrier molecule that delivers the radioactive label to the target (…

PET/MRI: technical and methodological aspects

Introduction Multimodal information is often required for diagnostic or research purposes as each imaging technique provides complementary data, for example about anatomy, physiology, or metabolism. Positron emission tomography (PET) measures the distribution and concentration of certain molecules in the body,…